News
-
-
-
COMMUNIQUÉ DE PRESSE
VisiRose Announces $3 Million Seed Financing Round to Advance Ocular Therapeutics
VisiRose Inc. announces $3 million seed financing round to advance lead ocular therapies for corneal diseases and severe eye conditions. Company collaborates with Provectus Biopharmaceuticals and University of Miami for innovative treatments